The mechanisms regulating the size of the cerebral cortex are poorly understood. Here, we demonstrate that the Rap1 guanine nucleotide exchange factor, C3G (Grf2, Rapgef1), controls the size of the cerebral precursor population. Mice lacking C3G show overproliferation of the cortical neuroepithelium. C3G-deficient neuroepithelial cells accumulate nuclear b-catenin and fail to exit the cell cycle in vivo. C3G mutant neural precursor cells fail to activate Rap1, exhibit activation of Akt/PKB, inhibition of the b-catenin-degrading enzyme, Gsk3b and accumulation of cytosolic and nuclear b-catenin when exposed to growth factors, in vitro. Our results show that the size of the cortical neural precursor population is controlled by C3G-mediated inhibition of the Ras signalling pathway.
Introduction
Intellectual capacity is tightly correlated with cerebral cortex size relative to body size, both during human evolution and among mammalian species. The increase in cerebral cortex size in higher mammals is predominantly an increase in surface area with relatively little increase in cortical thickness (Rakic, 1995) . It has been proposed that an increase in the neural precursor population before and during the first half of neurogenesis during prenatal development underlies the increase in cortical size Rakic, 1995) .
Understanding the genetic regulation of the size of the cerebral neural precursor population in vivo is in its infancy. Clearly molecular pathways must exist, which allow differential growth of specific brain areas by regulating the neural precursor population. Among molecules shown to regulate the size of the cerebral neural precursor population in vivo are fibroblast growth factor 2 (FGF2) and b-catenin. FGF2 has been shown to be essential for normal cerebral cortex expansion during development (Raballo et al, 2000) . Overexpression of degradation-resistant b-catenin leads to an immense expansion of the neuroepithelium (Chenn and Walsh, 2002) . However, how these molecules may relate to each other while regulating the neural precursor population is not known.
Growth factor signalling via the Ras pathway regulates many biological processes, including cell division, migration, differentiation and survival. Ras proteins are small GTPases that are activated by guanine exchange before stimulating downstream targets, including the mitogen-activated kinase/ extracellular signal-regulated kinase (Erk) and phosphatidylinositol-3 kinase (PI3K) pathways (Mitin et al, 2005) . Key regulatory elements of Ras signal transduction are guanine nucleotide exchange factors (Mitin et al, 2005) . C3G (Grf2, Rapgef1) is a guanine nucleotide exchange factor for Ras family members (Tanaka et al, 1994) . C3G is activated in response to extracellular signals, including epidermal growth factor (EGF), nerve growth factor (NGF) (York et al, 1998; Kao et al, 2001 ) and integrin binding (Arai et al, 1999; Uemura and Griffin, 1999) . C3G stimulates guanine nucleotide exchange predominantly on Rap1 (Ohba et al, 2001 ). Rap1 activation can reinforce or oppose the downstream consequences of Ras activation (reviewed in Stork, 2003) . For example, Rap1 activation can lead to the sustained activation of Erk in differentiating pheochromocytoma cells (PC12) (York et al, 1998; Kao et al, 2001) or inhibition of Erk in proliferating fibroblasts (Schmitt and Stork, 2002) . Very little is known about the circumstances under which C3G/Rap1 act as agonists or antagonists of Ras.
In vivo C3G is essential for embryonic development to proceed normally. C3G null embryos die around day 5.0 of gestation (Ohba et al, 2001) precluding the study of the function of C3G in nervous system development, where C3G is expressed at higher levels than elsewhere in the embryo. However, we previously generated a C3G hypomorphic allele, C3G gt , which produces less than 5% normal protein allowing survival of the C3G gt/gt mutant embryos up to embryonic day 14 (E14.5) (Voss et al, 2003) . C3G gt/gt mutant embryos die due to a blood vessel maturation defect (Voss et al, 2003) . Interestingly, C3G gt/gt mutant embryos display defects in the developing nervous system before the onset of blood vessel maturation. Lack of C3G causes abnormalities in the proliferating neural precursor population and in differentiating neurons. The role of C3G in neural precursors is the subject of this study.
We show here that C3G deficiency leads to an increase in nuclear b-catenin and causes a prominent increase of neural precursor proliferation in the cerebral cortex. Our findings suggest that C3G signalling is required to activate Rap1 in response to extracellular stimuli, restrict Akt/PKB activation, alleviate Gsk3b inhibition, limit cytosolic and nuclear accumulation of b-catenin, and to restrict the size of the cerebral cortex precursor population. We provide a functional link between one novel player, C3G, two downstream effectors, Akt/PKB and Gsk3b, and two known regulators, FGF2 and b-catenin, of the size of the cerebral cortex.
Results

C3G gene expression
The C3G gene is expressed in all cells at low levels (Voss et al, 2003) . Higher levels of C3G expression are observed throughout the neural tube at E9.5 and in the cerebrocortical neuroepithelium at E11.5 and E12.5 (Figure 1 ). C3G mutant embryos exhibit an overproliferation of the cerebrocortical neuroepithelium C3G gt/gt embryos exhibit an enlarged cerebrocortical neuroepithelium at E12.5 (Figure 2A versus B) . In contrast, the differentiation fields, where postmitotic neurons undergo differentiation, were reduced in size (Figure 2A versus B) . Outwardly, C3G gt/gt embryos were of normal size and indistinguishable from littermate controls. C3G gt/gt mutant mice display variable penetrance of phenotypic abnormalities. At E14.5, the cerebral neuroepithelium was either simply expanded (Figure 2C versus D) or organized in folds (Figure 2E versus F) to accommodate the enlarged cerebral tissues in a normal sized head (n ¼ 6, 3, and 3 mutants versus 6, 3, and 3 littermate controls at E12.5, E13.5 and E14.5, respectively). The extent and the cell density of the E12.5 cerebrocortical neuroepithelium ventricular zone were assessed on serial sections using the volumetric method of Cavalieri (Coggeshall, 1992) and the optical dissector method (West et al, 1991) , respectively ( Figure 2G-K) . The tissue volume of the ventricular proliferation zone per section ( Figure 2H ) and its cell density ( Figure 2I ) were highly significantly increased in the C3G gt/gt mutants compared to controls, which combined to an increased total number of cells per hemisphere in C3G gt/gt mutants ( Figure 2K ; n ¼ 5 C3G gt/gt mutant and 5 control embryos). In contrast, the E14.5 differentiation zone overlying the ventricular zone was reduced in size ( Figure 2M Figure 1 The C3G gene is expressed ubiquitously at low levels with higher levels of expression in the developing neuroepithelium. (A-C) Histochemical staining (blue) for activity of the b-galactosidase reporter gene inserted in the C3G gt allele (Voss et al, 2003) . Whole mount E9.5 (A) and sections of E11.5 forebrain (B, C) are shown. (D-L) Endogenous C3G gene activity was assessed by in situ hybridization on paraffin sections of E11.5 (D-F), E12.5 (G-I) and E15.5 (J-L) forebrain using a [ 35 S]-UTP-labelled C3G cRNA probe as described (Voss et al, 2003) . Bright field images are shown in (D, G, J), antisense probe hybridizations in (E, H, K) and sense probe controls in (F, I, L). The location of C3G mRNA molecules is revealed by precipitated silver grains, which appear white in the dark field images. Note the low levels of b-galactosidase staining and low density of silver grains, both reflecting the low level of C3G gene expression overall with slightly higher levels in the neuroepithelium. CNE, cerebrocortical neuroepithelium; GE, ganglionic eminences; Hi, hippocampal neuroepithelium. Scale bar equals 625 mm in (A), 227 mm in (B, D-I), 28 mm in (C) and 54 mm in (J-L).
An increase in cell number can be caused by three different mechanisms, namely an acceleration of the cell cycle, a failure to exit the cell cycle and a decrease in developmental cell death. We investigated these three options.
Cell death was assessed by TUNEL and corroborated by examining TUNEL-positive cells for chromatin condensation (n ¼ 3 E11.5 mutants and 3 littermate controls). No difference was observed in the number of TUNEL-positive cells within the neuroepithelial proliferation zone between C3G mutant and control brains (data not shown).
To assess the cell cycle length, we determined the fraction of neural precursor cells in S phase as compared to the total proliferating population by incorporation of the thymidine analogue, bromodeoxyuridine (BrdU) at E11.5 and E12.5 (n ¼ 3 mutants versus 3 littermate controls at each time point). In the developing neuroepithelium, varying lengths of the G 1 phase underlie variations observed in cell cycle length, whereas the length of the S phase is comparably constant . Therefore, a change in cell cycle length would lead to a change in the ratio of cells in the S phase over the total proliferating population (BrdU labelling index). Both the total number of cells in the proliferation zone and the number of cells in S phase of the cell cycle within the C3G mutant neuroepithelial proliferating zone were significantly elevated ( Figure 3A versus B, and C). As both parameters were increased proportionally, the BrdU labelling index was unchanged ( Figure 3C ), indicating that the relative lengths of S-and G 1 -phase were unaltered. We conclude that the length of the cell cycle is not likely to be changed significantly in C3G gt/gt mutants. Other parts of the developing brain and spinal cord showed a tendency towards higher BrdU incorporation. However, the overproliferation of the cerebrocortical neuroepithelium was highly significant, showing that C3G regulates the size of the neural precursor population most prominently in the cortex.
We assessed cell cycle exit by examining BrdU incorporation and staining for the cell cycle marker Ki67 at 0600 on E13.5, 12 h after a single BrdU injection at 1800 on E12.5 (n ¼ 3 mutants and 3 littermate controls). In this experiment, cells that have left the cell cycle after being exposed to BrdU in their last S-phase will stain strongly for BrdU (green) and weakly for Ki67 (red). Ki67 marks S-, G2-, M-and part of the G1-phase of the cell cycle. However, cells that have only recently exited the cell cycle still contain low levels of Ki67. Cells leaving the cell cycle during this period will also begin to migrate away from the ventricular zone. In contrast, those cells remaining in the cell cycle will undergo further cell division and dilute the BrdU label. These cells will stain weakly for BrdU and strongly for Ki67.
By comparing cell cycle exit in C3G gt/gt mutant ( Figure 3E ) with wild-type littermate controls ( Figure 3D ), we saw a substantial difference in the number of cells leaving the cell cycle 12 h after a pulse of BrdU. In the wild-type littermate control cortical neuroepithelium, a large number of brightly green, BrdU-positive cells have already reached the nascent preplate (asterix, Figure 3D ). In contrast, in the mutant cortical neuroepithelium, very few BrdU-positive cells have migrated away from the ventricular proliferation zone and almost no preplate (differentiation zone) is visible. Since these cells have only recently left the cell cycle, they still contain some Ki67 immunoreactivity. In contrast, the mutant ventricular zone contains a much higher density of strongly Ki67-positive cells and a larger number of cells with BrdU/ Ki67 double positive nuclei, in which the BrdU label has been diluted (insets in Figure 3D and E). These results are shown quantitatively in Figure 3F . We conclude that C3G deficient neural precursors are retained in the cell cycle and are more likely to give rise to further neural precursors as compared to control cells expressing normal levels of C3G. A failure to exit the cell cycle would be expected to affect the size of the differentiating population. Indeed, we observed a significant decrease in the volume of the cerebral differentiation fields in the C3G gt/gt mutants as compared to controls (16.5674.06 mm 3 Â10 6 versus 39.587 6.72 mm 3 Â10
6
, respectively, P ¼ 0.019). In contrast to the proliferation zones, the cell density in the C3G gt/gt mutant differentiation zones was not different between mutant and control (P ¼ 0.9163).
C3G deficiency leads to increased levels of cytosolic b-catenin and accumulation of b-catenin in the nucleus b-Catenin is a multifunctional protein with largely independent roles in cadherin-mediated cell adhesion and signal transduction (Miller et al, 1999) . In these two processes, b-catenin is an integral part of adherence junctions at the cell membrane and acts as a transcriptional regulator in the nucleus. As b-catenin has been implicated as a molecule regulating neural precursor proliferation (Chenn and Walsh, 2002) , we examined if C3G gt/gt neuroepithelium contained more nuclear b-catenin by immunohistochemistry combined with confocal microscopy ( Figure 4 ; n ¼ 3 mutants and 3 littermate controls each at E11.5, E12.5 and E14.5). As expected, strong b-catenin immunoreactivity near the cytoplasmic membranes reflecting b-catenin in adherence junction was found in both mutants and controls ( Figure 4A -F). As seen in control embryos at E12.5, the fraction of nuclear b-catenin is undetectable or very low ( Figure 4A and C). However, C3G gt/gt mutant embryos showed clearly detectable Figure 2 The cerebrocortical neuroepithelium overproliferates in C3G gt/gt mutant embryos. (A-F) Haematoxylin and eosin-stained coronal paraffin sections of littermate wild type (upper panels) and C3G gt/gt mutant embryos (lower panels) at E12.5 (A, B) and E14.5 (C-F). Note the expansion of the cerebral neuroepithelium parallel to the luminal surface (arrows in A-D) and the arrangement of the neuroepithelium in folds in C3G gt/gt embryos at E14.5 in the area of the cortical neuroepithelium (white arrow in F) and the hippocampal neuroepithelium (black arrows in F). In addition, there is a paucity of differentiating cells resulting in small differentiation fields of the ganglionic eminences (B versus A). CNE, cerebrocortical neuroepithelium; ET, epithalamus; GE, ganglionic eminence; Hi, hippocampal neuroepithelium. (G-K) Parameters of the cerebrocortical neuroepithelium were assessed quantitatively. Note that, while the rostro-caudal extent (G) is not different between C3G gt/gt mutants and littermate controls, the ventricular proliferation zone is significantly enlarged in C3G gt/gt mutants with respect to all other parameters assessed: (H) average tissue volume per section, P ¼ 0.0009; (I) cell density, Po0.0001; (J) total number of cells per section volume, Po0.0001; and (K) total number of cells per dorsal telencephalic hemisphere, P ¼ 0.0081, n ¼ 5 E12.5 C3G gt/gt mutant and 5 control embryos. ***Po0.001, **Po0.01. (L, M) In contrast to the ventricular proliferation zone (VZ), the overlying differentiation zone was reduced in size in the C3G gt/gt mutants at E14.5 (M versus L). Scale bar equals 245 mm in (A, B) and 192 mm in (C-F), 22 mm in (L, M). Data are expressed as means of two hemispheres of five embryos in each group7s.e.m. Data were analysed by 2 or 3-factorial analysis of variance (ANOVA) with genotype, experimental animal pair7rostro-caudal level as the independent factors followed by Fisher's post hoc test. levels of nuclear b-catenin immunoreactivity ( Figure 4B , D versus A, C, G). The increase in nuclear b-catenin in the mutant neuroepithelium was seen at E12.5 (Figure 4 ) and E14.5 (not depicted), the times when the greatest enlargement of the mutant cerebral neuroepithelium was observed. Changes in the subcellular distribution of b-catenin correlated with changes in proliferative activity, as they were not detected in areas of the embryos other than the cortical neuroepithelium. Likewise, there was no difference in the overall levels of b-catenin in C3G gt/gt mutant embryos as compared to controls.
To explore the accumulation of b-catenin further, we isolated cerebrocortical neural precursor cells from C3G individually isolated from 3 C3G gt/gt mutant and wild-type embryos; P ¼ 0.0009; similar results were also observed in a fourth pair of mutant and control cultures). The observed changes in nuclear b-catenin were opposite to, but similar in magnitude to those reported for neurons overexpressing Gsk3b (Lucas et al, 2001) . As expected, based on the observation by others (Peifer et al, 1994; Yost et al, 1996; Miller et al, 1999) and reported here, the cytosolic and nuclear levels of b-catenin rise concomitantly and the ratio of nuclear to cytosolic b-catenin was not significantly affected by C3G deficiency. As observed in vivo, the membrane-associated pool of b-catenin, reflecting b-catenin in adherence junctions, was not affected by C3G deficiency as assessed by cell fractionation and western analysis (data not shown).
We conclude that C3G is required to restrict cytosolic accumulation and hence nuclear localization of b-catenin within the cortical neural precursor population.
Inhibition of Gsk3b promotes proliferation of neural precursor cells in vitro
Nuclear b-catenin was first found to play an integral role as a transcriptional regulator in promotion of proliferation in cancer pathogenesis (Morin et al, 1997) . Many types of cancer show gain-of-function mutations in the b-catenin gene or loss of function in genes coding for proteins forming the b-catenin destruction complex. The b-catenin destruction complex subjects cytosolic b-catenin to proteasomal degradation. Central to the b-catenin destruction complex is glycogen synthase kinase 3b (Gsk3b) (Miller et al, 1999) . In order to assess if the observed nuclear accumulation of b-catenin could be causally related to an increase in the neural precursor population, we inhibited the b-catenin-degrading enzyme Gsk3b with lithium chloride, which has been shown to lead to accumulation of b-catenin (Klein and Melton, 1996; Stambolic et al, 1996) . We cultured whole telencephalic hemispheres and cerebral neural precursor cells with and without lithium chloride and assessed DNA synthesis by measuring [ 3 H]thymidine incorporation. We observed that lithium chloride caused an increase in DNA synthesis in telencephalic hemispheres ( Figure 5A ) and in neural precursor cells ( Figure 5B ). The effect of lithium chloride was dosedependent ( Figure 5C ). The morphology of the cultured neural precursor cell colonies was not altered by the presence of LiCl (Figure 5D versus E). Western analysis of the phosphorylation status of Gsk3b in dorsal telencephalic hemispheres cultured with or without LiCl confirmed increased Ser9 phosphorylation of Gsk3b in the presence of LiCl ( Figure 5F ), which correlates with Gsk3b inhibition (Cross et al, 1995) and an increase in cytosolic and nuclear b-catenin levels assessed by cell fractionation and Western analysis (2.6-and 1.3-fold, respectively, not depicted). This finding is consistent with a causative link between the increase in nuclear b-catenin in C3G gt/gt mutant embryos and the observed expansion of the cerebral neural precursor population.
b-Catenin is a downstream effector of Wnt signalling (Noordermeer et al, 1994; Siegfried et al, 1994) . Wnt genes are expressed in the developing cerebral cortex (Grove et al, 1998) . We examined the expression of Wnt7a, Wnt7b and Wnt2b by RNA in situ hybridization. The expression patterns and levels of these Wnt genes were not significantly changed in the C3G gt/gt embryos, showing that the patterning of the developing cerebral cortex was not affected by loss of C3G (data not shown).
Lack of C3G leads to an elevated phosphorylation of Erk, Akt/PKB and Gsk3b
C3G is a component of the Ras signalling pathway ( Figure 6A ). FGF2 and EGF, which are mitogens for neural precursor cells (Drago et al, 1991; Reynolds et al, 1992; Martens et al, 2000) , stimulate Ras and Erk activation as well as Ras and Akt/PKB activation ( Figure 6A ; Kamata and Feramisco, 1984; Whitman and Melton, 1992; Burgering and Coffer, 1995) . Akt/PKB activation in turn leads to inhibition of Gsk3b (Cross et al, 1995) . We utilized mutant and control cells to assess events downstream of C3G signalling. We analysed activation of Rap1, Erk1/2 and Akt/PKB and inhibition of Gsk3b as downstream events of FGF2 and EGF signalling in C3G gt/gt and wild-type neural precursor cells. Although embryonic neuroepithelial cells do not respond to EGF before E14.5, they acquire EGF-responsiveness within 2 days in culture with FGF2 (Ciccolini, 2001 ) and so EGFresponsiveness can be studied in proliferating neural precursor cell cultures. After incubation for 4 h without mitogens, we stimulated cells with FGF2, EGF, and/or insulin over a time course of 5 min to 4 h in vitro and examined phosphorylation of signal transduction proteins by Western analysis. Wild type and C3G gt/gt mutant cells tolerated 4 h without mitogen and resumed proliferation after mitogens were reapplied. When the cells were stimulated with normal proliferation medium, which contained FGF2, EGF and insulin, we observed a significantly and acutely enhanced phosphorylation of Akt/PKB on Ser473 ( Figure 6B and C), corresponding to activation of Akt/PKB (Alessi et al, 1996) , Gsk3b on Ser9 ( Figure 6B and D) , corresponding to inactivation of Gsk3b (Cross et al, 1995) and Erk1/2 on Thr203/ Tyr205 ( Figure 6B and E), corresponding to activation of Erk1/2 (Payne et al, 1991) . Phosphorylation of all three proteins was higher in C3G gt/gt cells as compared to wildtype controls (Figure 6B -E; n ¼ 3 mutant and four wild-type cell lines isolated from seven individual embryos). In addition, phosphorylation of Akt/PKB and Gsk3b was prolonged in C3G gt/gt cells ( Figure 6C and D).
C3G deficient neural precursor cells respond to FGF2 with enhanced phosphorylation of Akt/PKB and Gsk3b and to EGF with enhanced phosphorylation of Erk
When FGF2, EGF or insulin were used separately to stimulate C3G gt/gt and wild-type neural precursor cells, all three led to increased phosphorylation of Gsk3b, Akt/PKB and Erk1/2 (n ¼ 6 mutant and 6 control cell lines isolated from 12 individual embryos). Insulin had similar effects on protein phosphorylation in C3G gt/gt and wild-type cells (data not shown). In contrast, signalling events downstream of FGF2 and EGF were affected by lack of C3G.
FGF2 induced higher Akt and Gsk3b phosphorylation in C3G gt/gt neural precursor cells as compared to control cells ( Figure 6F and G), while it induced Erk1/2 phosphorylation (not depicted) to similar levels in both genotypes. In contrast, EGF-induced Erk1/2 phosphorylation was elevated in C3G gt/gt cells ( Figure 6H ), while EGF-induced phosphorylation of Akt/PKB and Gsk3b (not depicted) was unaffected by C3G deficiency.
An increase in neural precursor proliferation and greater effects downstream of FGF2, namely activation of Akt/PKB and inhibition of Gsk3b, and of the EGF-receptor, namely activation of Erk1/2, in the C3G-deficient cells are consistent with a role of C3G in limiting proliferation in response to FGF2 and EGF. These results suggest that in wild-type neural precursor cells C3G counteracts the phosphorylation (activation) of Akt/PKB and the Ser9-phosphorylation (inhibition) of Gsk3b in response to FGF2, as well as the phosphorylation (activation) of Erk1/2 in response to EGF-receptor activation.
C3G deficiency does not affect basal levels of activated Rap1, but abrogates the ability of cells to respond to external stimuli with Rap1 activation Rap1 has been reported as the major Ras family target of C3G in fibroblasts (Ohba et al, 2001) . We assessed the activation status of Rap1 in C3G gt/gt mutant and control neural precursor cells. Basal Rap1 activation was not affected by the lack of C3G (Figure 6I and insulin for 2 min Rap1-GTP was increased in wild type, but not in C3G gt/gt mutant cells ( Figure 6I ). Rap1-GTP was low in mutant and wild-type neural precursor cells after a short exposure to differentiation conditions on laminin without mitogens ( Figure 6J) . After 3 and 6 days in differentiation conditions, the wild type, but not C3G gt/gt mutants cells showed markedly increased Rap1-GTP ( Figure 6J ). Ras-GTP loading, as assessed by Raf-1-GST pull-down from total embryo lysates, increased significantly between E10.5 and E12.5 (P ¼ 0.0058), but was not different between C3G gt/gt mutants and controls at E10.5, E11.5 or E12.5 (not depicted). The Rap1 effector B-Raf was present in proliferating neural precursors in vivo and in vitro as well as in differentiating neural cells in vitro (Supplementary Figure 1) . The observed requirement of C3G for Rap1 activation in response to stimuli as well as the absence of an effect of C3G deficiency on basal Rap1-GTP levels are consistent with the findings in C3G mutant embryonic fibroblasts (Ohba et al, 2001 ).
In conclusion, C3G is required to activate Rap1 in neural cells in response to mitogen stimuli and during differentiation. Furthermore, C3G restricts Erk1/2 and Akt/PKB activation and alleviates Gsk3b inhibition in mitogen-stimulated neural precursor cells. Finally, C3G restricts cytosolic and nuclear accumulation of b-catenin in proliferating neural precursor cells.
Discussion
Molecular consequences of C3G activation C3G activates predominantly Rap1 (Ohba et al, 2001) . The downstream molecular effects of C3G-activated Rap1 vary dependent on the cell type, the specific stimulus and other contextual parameters (reviewed in Stork, 2003) . Rap1 can inhibit Erk1/2 or PI3K and Akt/PKB activation or, alternatively, induce activation of the same effectors (Stork, 2003) . The specific response to Rap1 activation may correlate with cell-substrate interaction. C3G-mediated Rap1 activation correlated with Erk inhibition in CHO cells cultured in suspension, but not in adherent CHO cells (Buensuceso and O'Toole, 2000) . In differentiating cell types, Rap1 activation can induce Erk activation, for example, differentiating PC12 cells and megakaryocytes (York et al, 1998 ; Garcia et al, Figure 4 C3G gt/gt cerebrocortical neural precursors exhibit elevated levels of nuclear b-catenin in vivo and in vitro. (A-F) Confocal immunofluorescence images of paraffin sections of E12.5 wild-type littermate (A, C, E) and C3G gt/gt mutant (B, D, F) cerebrocortical neuroepithelium stained for b-catenin. As expected, prominent b-catenin staining (red) is associated with the cell membranes reflecting the large amounts of b-catenin in adherence junctions. Nuclear b-catenin is visible in the C3G gt/gt neuroepithelium, but not in wild-type controls (B, D versus A, C). (E, F) An overlay with the nuclear counterstain bisbenzimide (blue). Note that the mutant nuclei appear more purple indicating double labelling. In proliferating neuroepithelial cells, the cytoplasm is scarce such that only a distinction of the membrane-associated compartment and the nuclei is possible (nuclear counterstain in E completely takes up b-catenin-free in spaces in A). (G, H) Quantification of bcatenin immunofluorescence in nuclei and membranes. Grey values in nuclear and membrane-associated areas of confocal images of eight cells per animal (n ¼ 3 animals for each genotype each at E11.5, E12.5) were analysed using NIHimage software. Data are presented and analysed as described for Figure 3 . Note that C3G gt/gt neuroepithelial cells show significantly higher levels of nuclear b-catenin than controls at E12.5, when the overproliferation is also observed on histological sections (P ¼ 0.001). In contrast, at E11.5, when the overproliferation is not yet histologically detectable, distribution of b-catenin is unaffected by lack of C3G. At the same time points, levels of b-catenin associated with the membranes, although lower in the mutants, are not significantly different from E12. gt/gt mutant and 3 wild-type littermate control embryos; P ¼ 0.0009). Densitometry data are presented as means of the total grey value volume7s.e.m. of b-catenin normalized for the cytosolic protein Hsp70 in the cytosolic fraction, for the nuclear protein Parp in the nuclear fraction and expressed relative to the mean wild-type control value. Data were analysed by two-factorial ANOVA with genotype and subcellular fraction as the two independent factors. Scale bar ¼ 7 mm in (A, B, E, F) , 4 mm in (C, D) and in (I, J). Confocal images were taken at 150 nm optical section thickness. **Po0.01, ***Po0.001. 2001). In contrast, Rap1 activation can lead to inhibition of Ras-effectors such as PI3K, Akt/PKB or Erk in some proliferating cell types, for example, fibroblasts and proliferating B-cells (Schmitt and Stork, 2002; Christian et al, 2003) . A mechanism put forward for these inhibitory effects of Rap1 on Ras signalling is that Rap1 may bind and sequester Ras effectors (Stork, 2003) . Our results suggest that proliferating neural precursor cells fall into the latter category, in which C3G/Rap1 activation results in inhibition of downstream events of growth factor receptor activation.
C3G restricts the response to mitogens FGF2 promotes neural precursor proliferation and it is required for the cerebral cortex to reach its full size. FGF2 mutant embryos exhibit proliferation deficits specifically in the cerebrocortical neuroepithelium (Raballo et al, 2000) . Our in vitro data suggest that C3G deficiency leads to a deregulation of FGF2-induced proliferation in the early neurogenic phase. EGF-receptors and responsiveness to EGF are found in the forebrain from the mid-neurogenic phase onwards (Martens et al, 2000) . Ablation of the EGF-receptor 
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leads to multiple defects including a reduction in brain size (Threadgill et al, 1995) , while deregulation of EGF-receptor/ Ras signalling in the adult brain leads to the formation of tumours (Lassman, 2004) , consistent with stimulatory effects of EGF-receptor signalling on brain cell proliferation. During the second half of the neurogenic phase, after the onset of EGF-responsiveness, neural precursor proliferation can be stimulated by both FGF2 and EGF-receptor activation. Our in vitro data suggest that C3G deficiency leads to deregulation of both FGF2 and EGF-receptor mediated neural precursor proliferation and result in substantially enhanced overproliferation after EGF-receptor responsiveness has been established. Consistent with the onset of EGF responsiveness between E13.5 and E14.5 (Reynolds et al, 1992; Martens et al, 2000; Caric et al, 2001) , we observed extensive overproliferation and fold formation in a subset of the E14.5 C3G gt/gt embryos.
C3G restricts nuclear b-catenin
We report here that C3G mutant embryos exhibit an overproliferation of the cerebral neuroepithelium showing that C3G is required in vivo to restrict the size of the cerebral cortex during development from E12.5 onwards. That is, the C3G mutant phenotype appears at the stage when cells begin to exit the cell cycle and differentiate into neurons. At this time C3G is required to restrict accumulation of b-catenin in the cytosol and hence transfer of b-catenin into the nucleus. b-Catenin is a multifunctional protein with largely independent roles in cadherin-mediated cell adhesion and transcriptional regulation (Miller et al, 1999) . The majority of b-catenin molecules are localized in adherence junctions at the cell membrane. Free cytosolic b-catenin is subject to Gsk3b-mediated degradation (Miller et al, 1999) . The transcriptional regulatory function of b-catenin requires stabilization and accumulation of cytosolic b-catenin by inhibition of Gsk3b and so an increase in nuclear b-catenin is associated with an increase in cytosolic b-catenin (Peifer et al, 1994; Yost et al, 1996; Miller et al, 1999; Nelson and Nusse, 2004) . The membrane-associated form of b-catenin is neither subject to destruction via cytosolic Gsk3b nor available for its transcriptional regulator function (Nelson and Nusse, 2004) . We observed a significant increase in cytosolic and nuclear b-catenin in C3G mutant neuroepithelial cells indicating that C3G limits cytosolic and nuclear b-catenin accumulation. Our findings are consistent with the observation that overexpression of degradation-resistant b-catenin induces a massive overproliferation of the cerebral neuroepithelium causing fold formation (Chenn and Walsh, 2002) . However, as expected, the C3G mutant phenotype is more subtle than the b-catenin overexpression phenotype.
Linking FGF2, C3G, Akt/PKB, b-catenin and proliferation Our in vitro data reveal a mechanism, by which C3G may restrict cerebral neural precursor proliferation and nuclear accumulation of b-catenin, that is, C3G via Rap1 limits FGF2-induced activation of Akt/PKB and thereby limits the inhibition of Gsk3b. Akt/PKB activation has been shown to result in inhibition of Gsk3b (Cross et al, 1995) . Inhibition of Gsk3b by overexpression of dominant negative Gsk3b leads to nuclear localization of b-catenin (Yost et al, 1996) . b-Catenin can promote cell proliferation by inducing cyclin D1 promoter activity (Tetsu and McCormick, 1999) . Together with these reports, our findings suggest that C3G controls the size of the cortical precursor population by restricting FGF2-induced, Akt/PKB-mediated inhibition of Gsk3b, which would otherwise allow nuclear translocation of b-catenin and enhanced precursor proliferation. C3G provides a negative feedback to proliferation signals exerted on the cerebrocortical neuroepithelium by FGF2.
C3G as a self-limiting mechanism for proliferative signals
Our results indicate a functional interaction between the C3G/Rap1 and the FGF2/Akt/Gsk3b/b-catenin pathway, as well as the EGF/Erk1/2 signalling pathway, providing a mechanism by which the size of the cerebral cortex is specified during development. We propose that growth factors elicit proliferative signals on cerebral neural precursors and concurrently activate a self-limiting mechanism, which clearly requires C3G in vivo. Western analysis of phosphorylated Akt (pAkt), Gsk3b (pGsk3b) and Erk2 (pErk2) as well as total Akt (tAkt) and Erk2 (tErk2) of wild-type littermate and C3G gt/gt mutant neural precursor cells stimulated for time durations indicated above with neural stem cell proliferation medium containing 10 ng/ml FGF2, 20 ng/ml EGF and 25 mg/ml insulin after 4 h in basal medium without mitogens. P ¼ proliferation medium prior to experiment, 0 ¼ after 4 h in basal medium without stimulation. (C-E) Quantification of protein phosphorylation in response to FGF2, EGF and insulin combined. C3G gt/gt mutant cells exhibit higher levels of phosphorylated Gsk3b (D, P ¼ 0.0046) and phosphorylated Erk2 (E, P ¼ 0.0072) and showed a tendency for higher levels of phosphorylated Akt (C, P ¼ 0.0693). (F-H) Quantification of protein phosphorylation in response to 20 ng/ml FGF2 (F, G) or 20 ng/ml EGF (H) individually. FGF2 stimulated more Akt (F, P ¼ 0.0021) and Gsk3b (G, P ¼ 0.0281) phosphorylation in C3G gt/gt cells as compared to control cells. EGF stimulated more phosphorylation of Erk2 in C3G gt/gt cells (H, P ¼ 0.0053). Densitometry data are presented as means of the total grey value volume7s.e.m. of phosphorylated protein normalized for total protein or normalized for total protein and expressed as percentage of wild-type control within each experiment and treatment group (B, C, D, n ¼ 3 mutant and 4 wild-type neural precursor cell lines isolated from individual embryos; E, F, G, n ¼ 6 mutant and six wild-type neural precursor cell lines isolated from individual embryos). Data were analysed by two-factorial ANOVA with duration of stimulation and genotype as the two independent factors followed by Fisher's post hoc test. (I, J) RalGDS pull-down of Rap1-GTP followed by Rap1 Western of total cell lysate of cultured C3G gt/gt mutant (MT) or wild-type (WT) neural precursor cells (I) unstimulated (0 0 ) or stimulated for 2 min (2 0 ) with 10 ng/ml FGF2, 20 ng/ml EGF and 25 mg/ ml insulin after 4 h in basal medium without mitogens (input 1 mg protein) or (J) plated onto laminin in the absence of mitogens for 1 h (1 h), 3 days (3 d) or 6 days (6 d; J). Numbers below the bands indicate fold changes over the unstimulated cells (I) or levels compared to 293T cells (J). Note that both C3G gt/gt mutant and control cells exhibit basal Rap1 activation, but only wild-type cells are able to respond to the mitogens with an increase in Rap1-GTP loading (I). Little Rap1-GTP is detectable during the early phase of differentiation (J, 1 h). However, during the course of differentiation, the wild-type cells exhibit higher levels of activation of Rap1 than C3G gt/gt mutant cells (J, 3 d, 6 d).
